BMPR2 and pulmonary arterial hypertension: A recent report in Respiratory Research by Austin and colleagues [10] showed that PAH patients with missense mutations in BMPR2 gene had more severe disease than patients with truncating mutation with a significant younger age at diagnosis, a younger age at death and a shorter survival from diagnosis to death or lung transplantation.